𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Clinical management of BRCA1- and BRCA2-associated breast cancer

✍ Scribed by Stephen E. Karp

Publisher
John Wiley and Sons
Year
2000
Tongue
English
Weight
115 KB
Volume
18
Category
Article
ISSN
8756-0437

No coin nor oath required. For personal study only.

✦ Synopsis

The recent discovery of the breast cancer-associated genes BRCA1 and BRCA2 has changed the clinical care provided to women at high risk of breast cancer. We will review what is currently known about the clinical management of patients who bear (or are suspected of bearing) mutations in either of these two genes. The issues related to establishing a diagnosis of inherited breast cancer, deciding which women are candidates for testing, the limitations of testing, and the predictive power of these tests are addressed. The prognostic features of cancers associated with a BRCA1 and BRCA2 mutation are reviewed. Further, guidelines for prophylaxis of women with a BRCA1 or BRCA2 mutation are given and recommendations are made for the care of mutation carriers with cancer. Semin.

πŸ“œ SIMILAR VOLUMES

Clinico–pathological characteristics of
Clinico–pathological characteristics of BRCA1- and BRCA2-related breast cancer
✍ Pierre O. Chappuis; Victoria Nethercot; William D. Foulkes πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 English βš– 56 KB πŸ‘ 1 views

Approximately 2% to 5% of all breast cancers are hereditary, meaning that the cancer predisposition is carried as a monogenic trait. Several highly penetrant breast cancer predisposing genes have been identified. These discoveries will permit a refined description of breast cancer occurring as part